Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
2016; Baishideng Publishing Group; Volume: 7; Issue: 5 Linguagem: Inglês
10.5306/wjco.v7.i5.387
ISSN2218-4333
AutoresCarlos A. Castañeda, Elizabeth A. Mittendorf, Sandro Casavilca‐Zambrano, Yun Wu, Miluska Castillo, Patricia Arboleda, Teresa Nunez, Henry Miller, Carlos Barrionuevo, Ketty Dolores-Cerna, Carolina Belmar-López, Julio E. Abugattas, Gabriela Calderón, Miguel De la Cruz, Manuel Cotrina, Jorge Dunstan, Henry Gómez, Tatiana Vidaurre,
Tópico(s)Immunotherapy and Immune Responses
ResumoTo determine influence of neoadjuvant-chemotherapy (NAC) over tumor-infiltrating-lymphocytes (TIL) in
Referência(s)